VerdictStats

Texas Attorney General

TX-AG v. Shire PLC, Baxter International Inc., Baxalta Inc., Viropharma Inc., Takeda Pharmaceuticals U.S.A., Inc., and Takeda Pharmaceuticals America

Settled

Shire PLC, Baxter International Inc., Baxalta Inc., Viropharma Inc., Takeda Pharmaceuticals U.S.A., Inc., and Takeda Pharmaceuticals America allegedly violated the TMFPA by providing, directly or indirectly, nursing and reimbursement services to Texas Medicaid providers for certain pharmaceutical drugs, as well as by paying clinical nurse educators to refer or recommend the drug Vyvanse to providers from January 2014 to December 2015, according to the TX-AG.

Summary generated from official Texas Attorney General press release

Source: Texas Attorney General Press Release ↗

Parties

Defendants / Respondents
  • Shire PLC
  • Baxter International Inc.
  • Baxalta Inc.
  • Viropharma Inc.
  • Takeda Pharmaceuticals U.S.A., Inc.
  • Takeda Pharmaceuticals America

Dates

Resolved
August 7, 2023
Published
August 8, 2023

Case Details

Industry
Pharmaceutical
Penalty Type
Multiple